Q21K (p.Gln21Lys) variant of TSLP (Thymic stromal lymphopoietin)
Q21K (p.Gln21Lys) in TSLP (Thymic stromal lymphopoietin) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.51 / 1. The record also includes population frequency data and structural context.
Q21K (p.Gln21Lys) variant details
- p.Gln21Lys
- NCI-TCGA Cosmic COSV6129
- cosmic curated COSV61291
- Variant assessed as somatic; moderate impact.
- Missense
- Variant Prioritization Score for Impact Estimate 0.512
- REVEL 0.32
- CADD 24.00
- PolyPhen-2 0.97
- SIFT 0.01
- UniProt: Variant assessed as somatic; moderate impact.
- Population evidence available
- Structural context available